Ultima PC: Sirolimus Eluting Coronary Stent System
World's Longest Studied
Drug Eluting Stent
New generation DES providing synergy of Biodegradable Polymer with microporous surface to enhance optimal performance.
Less Polymeric Load Compared to Other DES
- One million pores per cm2 with average depth of 2um ensures optimum drug release with minimal use of polymer
- Shellac Resin (Wax-free) ensures better polymer-drug binding with negligible polymer flaking during stent expansion
- Drug and Polymer are co-released in 30 days
Better Endothelialisation & Superior Strut Coverage
- Drug polymer matrix coated only on the abluminal side using patented stent coating technology for drug release only to target tissue
- No polymer on the luminal side ensures healthy endothelialisation and reduces the incidence of stent thrombosis
Technical Specification
Product Matrix/ Ordering Information*
Compliance Chart
Technical Data
Clinical Studies
Comparison of clinical outcomes at 10 years in patients treated with new-generation BP-SES versus new-generation PP-EES versus early generation SES.
